Answers are grounded in this paper and cite their sources.
Active surveillance finds high-risk Pseudomonas aeruginosa lineages driving outbreaks, suggesting urgent need for control measures.
The global rise of carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a significant threat to public health. Through active surveillance conducted between 2021 and 2022, we collected 92 distinct CRPA isolates and identified a clonal shift toward high-risk lineages ST235* and ST292. Whole-genome sequencing and phylogenomic analysis revealed that ST235*, a single-locus variant of epidemic ST235, exhibited broader antimicrobial resistance (AMR) and carried a nalD loss-of-function mutation, resulting in MexAB-OprM overexpression. Two ST235* isolates contained a hybrid resistance cassette with bla KPC-2 and bla TEM-1 , likely acquired through IS 26 -mediated transfer from Enterobacter hormaechei . Most ST292 isolates demonstrated an extensively drug-resistant phenotype with a bla CARB-2 -containing cassette and a chromosomally integrated tMexC3D-OprJ efflux system. Additionally, ST244 isolates possessed a bla VIM-2 cassette embedded within a Tn 402 transposition module (t niABQR-intI1 ). Multiple copies of tniABQR-intI1 carrying AMR genes were exclusively found in the genomes of ST244, representing a novel mechanism. The genomic plasticity of high-risk CRPA lineages emphasizes their capacity to acquire, amplify and disseminate AMR determinants. To combat the spread of CRPA, genomic surveillance and targeted infection control strategies are urgently required.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: